Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization.
Auteurs : Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Moussa Agha D, Fahmi H, Lewalle P, Fayyad-Kazan M, Merimi M Année : 2022 Journal : Front Cell Dev Biol
Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules.
Auteurs : Merimi M, Lagneaux L, Lombard CA, Agha DM, Bron D, Lewalle P, Meuleman N, Najimi M, Sokal EM, Najar M Année : 2021 Journal : Inflamm Res
New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways.
Auteurs : Bouhtit F, Najar M, Moussa Agha D, Melki R, Najimi M, Sadki K, Boukhatem N, Bron D, Meuleman N, Hamal A, Lagneaux L, Lewalle P, Merimi M Année : 2021 Journal : Molecules
Priming of mesenchymal stem cells with a hydrosoluble form of curcumin allows keeping their mesenchymal properties for cell-based therapy development.
Auteurs : Colin M, Dechêne L, Ceusters J, Niesten A, Demazy C, Lagneaux L, Zouaoui Boudjeltia K, Franck T, Van Antwerpen P, Renard P, Mathieu V, Serteyn D Année : 2021 Journal : J Cell Mol Med
Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic.
Auteurs : Merimi M, Lewalle P, Meuleman N, Agha DM, El-Kehdy H, Bouhtit F, Ayoub S, Burny A, Fahmi H, Lagneaux L, Najar M Année : 2021 Journal : J Clin Med